Comparing blood transfusion levels in ECMO patients
Part of Blood & lymphatic clinical trials.
This trial tests whether giving more or fewer red blood cell transfusions is better for adult patients on ECMO (a machine that helps your heart and lungs work). The goal is to find the best transfusion approach to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be on ECMO (a heart-lung support machine).
- You must be able to receive blood products (like blood transfusions).
- You cannot have refused blood transfusions for any reason (like religious beliefs).
- You must have started ECMO within the last 48 hours when you are screened.
- You must be expected to survive at least 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving blood in a personalized way, instead of a standard approach, is better for people on a heart-lung bypass machine (VA-ECMO) for heart-related shock. It may help find a safer blood transfusion strategy while you are critically ill.
This trial studies whether a change in how a veno-venous ECMO machine works can reduce “blood recirculation” (blood returning to the circuit too quickly) in people with severe lung failure. It may help improve oxygen levels in adults whose ARDS is not responding to standard treatment.
This study tests whether giving blood transfusions based on each patient's needs during and after heart surgery is safe and effective. It compares different transfusion thresholds to see which works better.
This study follows people who are on ECMO (a machine that supports heart and lung function) to see how they do and what their quality of life is like afterward. It helps doctors learn more about long-term recovery.
This study tests a more precise way to decide when to give red blood cell transfusions to ICU patients with mild anemia. It uses a measurement called ScvO2 (a marker of how well your body is using oxygen) to see if a transfusion is needed, which may help avoid unnecessary transfusions.
This study looks at whether giving red blood cell transfusions in a specific way is practical and safe for people receiving ECMO (a heart-lung support machine). It’s mainly a feasibility study, meaning the goal is to see if the plan can be carried out smoothly and safely.
Hear when a new Transfusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.